Medicine - Hematology and Medical Oncology

Research output

Research output per year 1949 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

• 294952 Citations
• 233 h-index
• 4028 Article
• 684 Review article
• 251 Letter
• 202 Comment/debate
• 303 More
  • 131 Chapter
  • 100 Editorial
  • 41 Short survey
  • 12 Conference contribution
  • 6 Foreword/postscript
  • 5 Book
  • 5 Paper
  • 3 Conference article

Research output per year

Research output per year

Search results

• 2023

  Erratum: Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements (Communications biology (2022) 5 1 (1295))

  Kimmerling, R. J., Stevens, M. M., Olcum, S., Minnah, A., Vacha, M., LaBella, R., Ferri, M., Wasserman, S. C., Fujii, J., Shaheen, Z., Sundaresan, S., Ribadeneyra, D., Jayabalan, D. S., Agte, S., Aleman, A., Criscitiello, J. A., Niesvizky, R., Luskin, M. R., Parekh, S., Rosenbaum, C. A., & 2 othersTamrazi, A. & Reid, C. A., 6 Jan 2023, In: Communications Biology. 6, 1, p. 15 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access
• 2022

  Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer (Nature Cancer, (2022), 3, 8, (927-931), 10.1038/s43018-022-00400-2)

  Spring, L. M., Han, H., Liu, M. C., Hamilton, E., Irie, H., Santa-Maria, C. A., Reeves, J., Pan, P., Shan, M., Tang, Y., Graham, J. R., Hazard, S., Ellisen, L. W. & Isakoff, S. J., Sep 2022, In: Nature Cancer. 3, 9, p. 1138 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • niraparib 100%
  • Ovarian Neoplasms 49%
  • Reading 47%
  • Breast Neoplasms 34%
  • Neoplasms 17%

• Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)

  Marron, T. U., Galsky, M. D., Taouli, B., Fiel, M. I., Ward, S., Kim, E., Yankelevitz, D., Doroshow, D., Guttman-Yassky, E., Ungar, B., Mehandru, S., Golas, B. J., Labow, D., Sfakianos, J., Nair, S. S., Chakravarty, D., Buckstein, M., Song, X., Kenigsberg, E., Gnjatic, S., & 6 othersBrown, B. D., Sparano, J., Tewari, A., Schwartz, M., Bhardwaj, N. & Merad, M., Aug 2022, In: Nature Medicine. 28, 8, p. 1723 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Drug Discovery 100%
  • Names 92%
  • Medicine 70%
  • Clinical Trials 63%
  • Drug 51%

• Cancer vaccines

  Schiller, J. T., Lowy, D. R., Frazer, I. H., Finn, O. J., Vilar, E., Lyerly, H. K., Gnjatic, S., Zaidi, N., Ott, P. A., Balachandran, V. P., Dietrich, P. Y., Migliorini, D., Vonderheide, R. H. & Domchek, S. M., 13 Jun 2022, In: Cancer Cell. 40, 6, p. 559-564 6 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Cancer Vaccines 100%
  • Vaccines 61%
  • Pandemics 43%
  • Antigens 26%
  4 Scopus citations

• Can THEM6 targeting stop resistance to prostate cancer treatment?

  Chattopadhyay, M. & Germain, D., 7 Mar 2022, In: EMBO Molecular Medicine. 14, 3, e15504.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Prostatic Neoplasms 100%
  • Unfolded Protein Response 78%
  • Endoplasmic Reticulum 60%
  • Androgens 57%
  • Castration 34%

• CD8⁺ T cells: An ineffective armor against prolonged COVID-19 in cancer patients

  Van Oekelen, O. & Parekh, S., 19 Jul 2022, In: Cell Reports Medicine. 3, 7, 100695.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • T-Lymphocytes 100%
  • Cell- and Tissue-Based Therapy 76%
  • B-Lymphocytes 62%
  • Viruses 53%
  • Neoplasms 52%

• Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals (Clinical Proteomics, (2022), 19, 1, (34), 10.1186/s12014-022-09371-z)

  The Mount Sinai COVID-19 Biobank Team, Dec 2022, In: Clinical Proteomics. 19, 1, 40.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Beckmann Reaction 100%
  • Names 60%
  • Sex Characteristics 59%
  • Proteomics 58%
  • Publications 52%

• Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021” [Eur Urol 82(1):6–11] (European Urology (2022) 82(1) (6–11), (S0302283822016505), (10.1016/j.eururo.2022.02.010))

  Turco, F., Armstrong, A., Attard, G., Beer, T. M., Beltran, H., Bjartell, A., Bossi, A., Briganti, A., Bristow, R. G., Bulbul, M., Caffo, O., Chi, K. N., Clarke, C., Clarke, N., Davis, I. D., de Bono, J., Duran, I., Eeles, R., Efstathiou, E., Efstathiou, J., & 66 othersEvans, C. P., Fanti, S., Feng, F. Y., Fizazi, K., Frydenberg, M., George, D., Gleave, M., Halabi, S., Heinrich, D., Higano, C., Hofman, M. S., Hussain, M., James, N., Jones, R., Kanesvaran, R., Khauli, R. B., Klotz, L., Leibowitz, R., Logothetis, C., Maluf, F., Millman, R., Morgans, A. K., Morris, M. J., Mottet, N., Mrabti, H., Murphy, D. G., Murthy, V., Oh, W. K., Ekeke, O. N., Ost, P., O'Sullivan, J. M., Padhani, A. R., Parker, C., Poon, D. M. C., Pritchard, C. C., Rabah, D. M., Rathkopf, D., Reiter, R. E., Rubin, M., Ryan, C. J., Saad, F., Sade, J. P., Sartor, O., Scher, H. I., Shore, N., Skoneczna, I., Small, E., Smith, M., Soule, H., Spratt, D., Sternberg, C. N., Suzuki, H., Sweeney, C., Sydes, M., Taplin, M. E., Tilki, D., Tombal, B., Türkeri, L., Uemura, H., Uemura, H., van Oort, I., Yamoah, K., Ye, D., Zapatero, A., Gillessen, S. & Omlin, A., Jul 2022, In: European Urology. 82, 1, p. e18-e19

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Urology 100%
  • Pandemics 95%
  • Consensus 85%
  • Prostatic Neoplasms 71%
  • Emotions 70%

• Dark genome, bright ideas: Recent approaches to harness transposable elements in immunotherapies

  Reid Cahn, A., Bhardwaj, N. & Vabret, N., 8 Aug 2022, In: Cancer Cell. 40, 8, p. 792-797 6 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • DNA Transposable Elements 100%
  • Immunotherapy 68%
  • Genome 52%
  • Human Genome 27%
  • Neoplasms 25%
  1 Scopus citations

• Does Circulating Tumor DNA Measure Up to Prostate-Specific Antigen?

  Jun, T. & Oh, W. K., Jul 2022, In: JAMA Oncology. 8, 7, p. 973-974 2 p.

  Research output: Contribution to journal › Comment/debate
  1 Scopus citations

• Guidance for Use and dosing of Selinexor in Multiple Myeloma in 2021: Consensus From International Myeloma Foundation Expert Roundtable

  Nooka, A. K., Costa, L. J., Gasparetto, C. J., Richardson, P. G., Siegel, D. S., Chari, A., Lentzsch, S., Jagannath, S. & Mikhael, J., Jul 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 7, p. e526-e531

  Research output: Contribution to journal › Comment/debate

  • selinexor 100%
  • Multiple Myeloma 53%
  • exportin 1 protein 23%
  • Dexamethasone 18%
  • Tumor Suppressor Proteins 18%
  3 Scopus citations

• JAK Inhibitors in the Treatment of Myelofibrosis

  Levavi, H., Hoffman, R. & Marcellino, B. K., Jul 2022, In: Clinical Advances in Hematology and Oncology. 20, 7, p. 456-468 13 p.

  Research output: Contribution to journal › Comment/debate

  • Janus Kinase Inhibitors 100%
  • Primary Myelofibrosis 89%
  • Splenomegaly 53%
  • Extramedullary Hematopoiesis 34%
  • Drug and Narcotic Control 27%
  2 Scopus citations

• MDS/AML with del5q: An acquired “laminopathy”?

  Papapetrou, E. P., 7 Apr 2022, In: Cell Stem Cell. 29, 4, p. 498-499 2 p.

  Research output: Contribution to journal › Comment/debate

  • lamin B1 100%
  • Neutrophils 46%
  • Stem Cells 44%
  • Genes 24%
  • Neoplasms 19%

• Metastasis

  Lyden, D., Ghajar, C. M., Correia, A. L., Aguirre-Ghiso, J. A., Cai, S., Rescigno, M., Zhang, P., Hu, G., Fendt, S. M., Boire, A., Weichselbaum, R. R. & Katipally, R. R., 8 Aug 2022, In: Cancer Cell. 40, 8, p. 787-791 5 p.

  Research output: Contribution to journal › Comment/debate

  • Neoplasm Metastasis 100%
  • Neoplasms 52%
  • Cause of Death 42%
  • Immune System 42%
  • Therapeutics 8%
  2 Scopus citations

• Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery

  Marron, T. U., Galsky, M. D., Taouli, B., Fiel, M. I., Ward, S., Kim, E., Yankelevitz, D., Doroshow, D., Guttman, E., Ungar, B., Mehandru, S., Golas, B. J., Labow, D., Sfakianos, J., Nair, S. S., Chakravarty, D., Buckstein, M., Song, X., Kenigsberg, E., Gnjatic, S., & 6 othersBrown, B. D., Sparano, J., Tewari, A., Schwartz, M., Bhardwaj, N. & Merad, M., Apr 2022, In: Nature Medicine. 28, 4, p. 626-629 4 p.

  Research output: Contribution to journal › Comment/debate
  2 Scopus citations

• Not just neighbours: positive feedback between tumour-associated macrophages and exhausted T cells

  Lubitz, G. S. & Brody, J. D., Jan 2022, In: Nature Reviews Immunology. 22, 1, p. 3 1 p.

  Research output: Contribution to journal › Comment/debate
  3 Scopus citations

• Ruxolitinib in patients with polycythemia vera with hydroxyurea resistance or intolerance

  Venugopal, S. & Mascarenhas, J., Jul 2022, In: The Lancet Haematology. 9, 7, p. e462-e463

  Research output: Contribution to journal › Comment/debate
• 2021

  A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma

  Wotman, M. T., Miles, B. A., Bakst, R. L. & Posner, M. R., 1 Dec 2021, In: Cancer. 127, 23, p. 4330-4338 9 p.

  Research output: Contribution to journal › Comment/debate
  3 Scopus citations

• Author Correction: Sampling the host response to SARS-CoV-2 in hospitals under siege (Nature Medicine, (2020), 26, 8, (1157-1158), 10.1038/s41591-020-1004-3)

  The Mount Sinai COVID-19 Biobank Team, Mar 2021, In: Nature Medicine. 27, 3, p. 560 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Stevens Reaction 100%
  • SARS Virus 93%
  • Sampling 52%
  • Error 47%
  • Medicine 46%

• Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis (Blood Cancer Journal, (2019), 9, 12, (97), 10.1038/s41408-019-0261-1)

  Shah, N. N., Ahn, K. W., Litovich, C., Sureda, A., Kharfan-Dabaja, M. A., Awan, F. T., Ganguly, S., Gergis, U., Inwards, D., Karmali, R., Lazaryan, A., Lekakis, L., Munshi, P., Nathan, S., Saad, A. A., Solh, M., Steinberg, A., Vij, R., Wood, W. A., Fenske, T. S., & 2 othersSmith, S. & Hamadani, M., Apr 2021, In: Blood Cancer Journal. 11, 4, 82.

  Research output: Contribution to journal › Comment/debate

  Open Access

• Corrigendum to ‘Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis’ [J Hepatol 75 (2021) 865–878](S0168827821003263)(10.1016/j.jhep.2021.04.049)

  Pinyol, R., Torrecilla, S., Wang, H., Montironi, C., Piqué-Gili, M., Torres-Martin, M., Wei-Qiang, L., Willoughby, C. E., Ramadori, P., Andreu-Oller, C., Taik, P., Lee, Y. A., Moeini, A., Peix, J., Faure-Dupuy, S., Riedl, T., Schuehle, S., Oliveira, C. P., Alves, V. A., Boffetta, P., & 15 othersLachenmayer, A., Roessler, S., Minguez, B., Schirmacher, P., Dufour, J. F., Thung, S. N., Reeves, H. L., Carrilho, F. J., Chang, C., Uzilov, A. V., Heikenwalder, M., Sanyal, A., Friedman, S. L., Sia, D. & Llovet, J. M., Dec 2021, In: Journal of Hepatology. 75, 6, p. 1515 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • 5-chloro-3-tert-butyl-2'-chloro-4'-nitrosalicylanilide 100%
  • Fatty Liver 63%
  • Publications 48%
  • Hepatocellular Carcinoma 47%
  2 Scopus citations

• Erratum: A randomized trial of combined PD-L1 and CTLA-4 inhibition with targeted low-dose or hypofractionated radiation for patients with metastatic colorectal cancer (Clinical Cancer Research (2021) 27 (2470-2480) DOI: 10.1158/1078-0432.CCR-20-4632)

  Monjazeb, A. M., Giobbie-Hurder, A., Lako, A., Thrash, E. M., Brennick, R. C., Kao, K. Z., Manuszak, C., Gentzler, R. D., Tesfaye, A., Jabbour, S. K., Alese, O. B., Rahma, O. E., Cleary, J. M., Sharon, E., Mamon, H. J., Cho, M., Streicher, H., Chen, H. X., Ahmed, M. M., Mariño-Enríquez, A., & 14 othersKim-Schulze, S., Gnjatic, S., Maverakis, E., Marusina, A. I., Merleev, A. A., Severgnini, M., Pfaff, K. L., Lindsay, J., Weirather, J. L., Ranasinghe, S., Spektor, A., Rodig, S. J., Hodi, F. S. & Schoenfeld, J. D., 1 Sep 2021, In: Clinical Cancer Research. 27, 17, p. 4940 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Radiation Dose Hypofractionation 100%
  • Names 45%
  • Psychological Inhibition 39%
  • Colorectal Neoplasms 38%
  • Emotions 19%
  2 Scopus citations

• Erratum: Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: The Golestan cohort study (International Journal of Epidemiology (2020) DOI: 10.1093/ije/dyaa126)

  Nalini, M., Khoshnia, M., Kamangar, F., Sharafkhah, M., Poustchi, H., Pourshams, A., Roshandel, G., Gharavi, S., Zahedi, M., Norouzi, A., Sotoudeh, M., Nikmanesh, A., Brennan, P., Boffetta, P., Dawsey, S. M., Abnet, C. C., Malekzadeh, R. & Etemadi, A., 1 Feb 2021, In: International Journal of Epidemiology. 50, 1, p. 353 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Opiate Alkaloids 100%
  • Epidemiology 72%
  • Cohort Studies 63%
  • Mortality 46%

• Repeat elements amplify TLR signaling

  O’Donnell, T. & Vabret, N., Dec 2021, In: Nature Reviews Immunology. 21, 12, p. 760 1 p.

  Research output: Contribution to journal › Comment/debate
  2 Scopus citations

• Super(antigen) target for SARS-CoV-2

  Brown, M. & Bhardwaj, N., Feb 2021, In: Nature Reviews Immunology. 21, 2, p. 72 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access
  6 Scopus citations

• The Case | Proteinuria in a patient with hematopoietic stem cell transplantation

  Bonilla, M., Bijol, V., Wanchoo, R., Keyzner, A. & Jhaveri, K. D., May 2021, In: Kidney International. 99, 5, p. 1249-1250 2 p.

  Research output: Contribution to journal › Comment/debate
  1 Scopus citations
• 2020

  Advancing scientific knowledge in times of pandemics

  The Sinai Immunology Review Project, Trainees & Faculty, 1 Jun 2020, In: Nature Reviews Immunology. 20, 6, p. 338 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access
  28 Scopus citations

• A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

  The COVID-19 and Cancer Consortium, 14 Dec 2020, In: Cancer Cell. 38, 6, p. 761-766 6 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Patient Participation 100%
  • Pandemics 93%
  • Electronic Health Records 90%
  • Neoplasms 85%
  • Eating 66%
  15 Scopus citations

• Author Correction: A conserved dendritic-cell regulatory program limits antitumour immunity (Nature, (2020), 580, 7802, (257-262), 10.1038/s41586-020-2134-y)

  Maier, B., Leader, A. M., Chen, S. T., Tung, N., Chang, C., LeBerichel, J., Chudnovskiy, A., Maskey, S., Walker, L., Finnigan, J. P., Kirkling, M. E., Reizis, B., Ghosh, S., D’Amore, N. R., Bhardwaj, N., Rothlin, C. V., Wolf, A., Flores, R., Marron, T., Rahman, A. H., & 3 othersKenigsberg, E., Brown, B. D. & Merad, M., 25 Jun 2020, In: Nature. 582, 7813, p. E17

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Dendritic Cells 100%
  • Immunity 91%
  5 Scopus citations

• Author Correction: Sampling the host response to SARS-CoV-2 in hospitals under siege (Nature Medicine, (2020), 26, 8, (1157-1158), 10.1038/s41591-020-1004-3)

  The Mount Sinai COVID-19 Biobank Team, 1 Sep 2020, In: Nature Medicine. 26, 9, p. 1493 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • SARS Virus 100%
  • Names 64%
  • Sampling 55%
  • Error 50%
  • Medicine 49%

• Consensus Recommendations for the Clinical Management of Patients With Multiple Myeloma Treated With Selinexor

  Mikhael, J., Noonan, K. R., Faiman, B., Gleason, C., Nooka, A. K., Costa, L. J., Jagannath, S., Richardson, P. G., Siegel, D., Chari, A. & Lentzch, S., Jun 2020, In: Clinical Lymphoma, Myeloma and Leukemia. 20, 6, p. 351-357 7 p.

  Research output: Contribution to journal › Comment/debate
  12 Scopus citations

• COVID-19: Staging of a New Disease

  Cordon-Cardo, C., Pujadas, E., Wajnberg, A., Sebra, R., Patel, G., Firpo-Betancourt, A., Fowkes, M., Sordillo, E., Paniz-Mondolfi, A., Gregory, J., Krammer, F., Simon, V., Isola, L., Soon-Shiong, P., Aberg, J. A., Fuster, V. & Reich, D. L., 9 Nov 2020, In: Cancer Cell. 38, 5, p. 594-597 4 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Coronavirus 100%
  • Benchmarking 14%
  • Neoplasm Staging 14%
  • Clinical Decision-Making 13%
  • Viruses 8%
  29 Scopus citations

• Cross-Presentation of Tumor Antigens Is Ruled by Synaptic Transfer of Vesicles among Dendritic Cell Subsets

  Balan, S. & Bhardwaj, N., 8 Jun 2020, In: Cancer Cell. 37, 6, p. 751-753 3 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Cross-Priming 100%
  • Synaptic Vesicles 82%
  • Neoplasm Antigens 75%
  • Dendritic Cells 63%
  • Lymph Nodes 16%
  10 Scopus citations

• Erratum: Association of ionizing radiation dose from common medical diagnostic procedures and lymphoma risk in the Epilymph case-control study (PLoS ONE (2020) 15: 7 (e0235658) DOI: 10.1371/journal.pone.0235658)

  Pasqual, E., Turner, M. C., Gracia-Lavedan, E., Casabonne, D., Benavente, Y., Thierry-Chef, I., Maynadié, M., Cocco, P., Staines, A., Foretova, L., Nieters, A., Boffetta, P., Brennan, P., Cardis, E. & de Sanjose, S., Dec 2020, In: PLoS ONE. 15, 12 December, e0243396.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Ionizing Radiation 100%
  • Names 92%
  • Lymphoma 80%
  • Case-Control Studies 78%

• Erratum: Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM (Blood Advances (2018) 2:13 (1608-1615) DOI: 10.1182/bloodadvances.2018017186)

  Jagannath, S., Abonour, R. & Durie, B. G. M., 11 Feb 2020, In: Blood advances. 4, 3, p. 444 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Multiple Myeloma 100%
  • Therapeutics 16%

• Erratum: Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers (Blood cancer discovery (2020) 1 3 (234-243))

  Hultcrantz, M., Richter, J., Rosenbaum, C. A., Patel, D., Smith, E. L., Korde, N., Lu, S. X., Mailankody, S., Shah, U. A., Lesokhin, A. M., Hassoun, H., Tan, C., Maura, F., Derkach, A., Diamond, B., Rossi, A., Pearse, R., Madduri, D., Chari, A., Kaminetzky, D., & 10 othersBraunstein, M. J., Gordillo, C., Reshef, R., Taur, Y., Davies, F. E., Jagannath, S., Niesvizky, R., Lentzsch, S., Morgan, G. J. & Landgren, O., 1 Nov 2020, In: Blood cancer discovery. 1, 3, p. 290 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Multiple Myeloma 100%
  • Cohort Studies 68%
  • Infections 48%
  • Neoplasms 32%
  6 Scopus citations

• Evaluation of recent evidence on the solubility of beryllium compounds and cancer risk

  Boffetta, P., Fordyce, T. & Leonhard, M., 2020, (Accepted/In press) In: European Journal of Cancer Prevention. p. 186-190 5 p.

  Research output: Contribution to journal › Comment/debate
  1 Scopus citations

• Interferon-α: alternative first- or second-line therapeutic option for polycythaemia vera

  Mascarenhas, J., Mar 2020, In: The Lancet Haematology. 7, 3, p. e178-e179

  Research output: Contribution to journal › Comment/debate
  1 Scopus citations

• SARS-CoV-2: the many pros of targeting PLpro

  McClain, C. B. & Vabret, N., 1 Dec 2020, In: Signal Transduction and Targeted Therapy. 5, 1, 223.

  Research output: Contribution to journal › Comment/debate

  Open Access
  28 Scopus citations

• The "New Normal" of Cancer Treatment Delays Is Nothing New

  Baum, L. V. M., Kline, K. & Smith, C. B., 1 Dec 2020, In: JAMA network open. 3, 12, p. e2030507

  Research output: Contribution to journal › Comment/debate

  Open Access
  1 Scopus citations

• Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry

  CONNECT MM Registry Investigators, May 2020, In: Clinical Lymphoma, Myeloma and Leukemia. 20, 5, p. 272-276 5 p.

  Research output: Contribution to journal › Comment/debate

  Open Access
  7 Scopus citations

• Visualizing Cancer

  Krummel, M., Hu, K., de Vries, E. G. E., Goetz, J. G., Passaro, D., Subramaniam, S., Misteli, T., Skala, M., Bravo-Cordero, J. J. & Sutcliffe, J. L., 14 Dec 2020, In: Cancer Cell. 38, 6, p. 753-756 4 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Clinical Decision-Making 100%
  • Neoplasms 91%
  3 Scopus citations

• War and pandemics: Catalysts for medical advancement

  Barr, J., Doroshow, D. B. & Montgomery, S. P., 1 Oct 2020, In: Journal of Trauma and Acute Care Surgery. 89, 4, p. e95-e96

  Research output: Contribution to journal › Comment/debate
  1 Scopus citations
• 2019

  Correction: Recent developments and therapeutic strategies against hepatocellular carcinoma (Cancer Research (2019) 79 (4326–4330) DOI: 10.1158/0008-5472.CAN-19-0803)

  Yarchoan, M., Agarwal, P., Villanueva, A., Rao, S., Dawson, L., Karasic, T., Llovet, J., Finn, R., Groopman, J., El-Serag, H., Monga, S., Wang, X. W., Karin, M., Schwartz, R., Tanabe, K., Roberts, L., Gunaratne, P., Tsung, A., Brown, K., Lawrence, T., & 15 othersSalem, R., Singal, A., Kim, A., Rabiee, A., Resar, L., Meyer, J., Hoshida, Y., He, A. R., Ghoshal, K., Ryan, P., Jaffee, E., Guha, C., Mishra, L., Coleman, N. & Ahmed, M., 15 Nov 2019, In: Cancer Research. 79, 22, p. 5897 1 p.

  Research output: Contribution to journal › Comment/debate

  • Disclosure 100%
  • Liver Neoplasms 90%
  • Hepatocellular Carcinoma 73%
  • Emotions 71%
  • Therapeutics 14%
  4 Scopus citations

• Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

  Ferrari, A. C., Alumkal, J. J., Stein, M. N., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R. & Beer, T. M., 15 Apr 2019, In: Clinical Cancer Research. 25, 8, p. 2672 1 p.

  Research output: Contribution to journal › Comment/debate

  • Panobinostat 100%
  • bicalutamide 93%
  • Castration 69%
  • Epigenomics 54%
  • Prostatic Neoplasms 49%

• Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT (Bone Marrow Transplantation, (2019), 54, 5, (648-661), 10.1038/s41409-018-0339-6)

  Inamoto, Y., Petriček, I., Burns, L., Chhabra, S., DeFilipp, Z., Hematti, P., Rovó, A., Schears, R., Shah, A., Agrawal, V., Al-Khinji, A., Ahmed, I., Ali, A., Aljurf, M., Alkhateeb, H., Beitinjaneh, A., Bhatt, N., Buchbinder, D., Byrne, M., Callander, N., & 29 othersFahnehjelm, K., Farhadfar, N., Gale, R. P., Ganguly, S., Hildebrandt, G. C., Horn, E., Jakubowski, A., Kamble, R. T., Law, J., Lee, C., Nathan, S., Penack, O., Pingali, R., Prasad, P., Pulanic, D., Rotz, S., Shreenivas, A., Steinberg, A., Tabbara, K., Tichelli, A., Wirk, B., Yared, J., Basak, G. W., Battiwalla, M., Duarte, R., Savani, B. N., Flowers, M. E. D., Shaw, B. E. & Valdés-Sanz, N., 1 May 2019, In: Bone Marrow Transplantation. 54, 5, p. 782-783 2 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Cell Transplantation 100%
  • Bone Marrow Transplantation 94%
  • Quality of Life 59%
  • Transplants 57%
  • Eye 57%

• Correction: Transmission bottleneck size estimation from pathogen deep-sequencing data, with an application to human influenza A virus (Journal of Virology (2017) 91:14 (e00171-17) DOI: 10.1128/JVI.00171-17)

  Leonard, A. S., Weissman, D. B., Greenbaum, B., Ghedin, E. & Koelle, K., 1 Sep 2019, In: Journal of Virology. 93, 17, e00936-19.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • human influenza 100%
  • virology 86%
  • Virology 84%
  • high-throughput nucleotide sequencing 76%
  • Influenza A virus 71%
  2 Scopus citations

• Correction: Prostate cancer in world trade center responders demonstrates evidence of an inflammatory cascade (Molecular Cancer Research (2019) 17 (1605–1612) DOI: 10.1158/1541-7786.MCR-19-0115.Epub)

  Gong, Y., Wang, L., Yu, H., Alpert, N., Cohen, M. D. & Prophete, C., 1 Aug 2019, In: Molecular Cancer Research. 17, 8, p. 1774 1 p.

  Research output: Contribution to journal › Comment/debate

  • Disclosure 100%
  • Prostatic Neoplasms 71%
  • Emotions 71%
  • Neoplasms 29%

• Corrigendum: Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: A randomized, double-blind, multicenter Phase II trial (Annals of Oncology (2016) 27 (2196-2203) DOI: 10.1093/annonc/mdw423)

  Yoon, H. H., Bendell, J. C., Braiteh, F. S., Firdaus, I., Philip, P. A., Cohn, A. L., Lewis, N., Anderson, D. M., Arrowsmith, E., Schwartz, J. D., Gao, L., Hsu, Y., Xu, Y., Ferry, D., Alberts, S. R. & Wainberg, Z. A., 1 Dec 2019, In: Annals of Oncology. 30, 12, p. 2016 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • ramucirumab 100%
  • Esophagogastric Junction 79%
  • National Cancer Institute (U.S.) 71%
  • National Institutes of Health (U.S.) 64%
  • Adenocarcinoma 48%
  2 Scopus citations

• Corrigendum: Pattern recognition receptors: Immune targets to enhance cancer immunotherapy (Annals of Oncology (2017) 28:8 (1756-1766) DOI: 10.1093/annonc/mdx179)

  Shekarian, T., Valsesia-Wittmann, S., Brody, J., C Michallet, M., Depil, S., Caux, C. & Marabelle, A., 1 Dec 2019, In: Annals of Oncology. 30, 12, p. 2017 1 p.

  Research output: Contribution to journal › Comment/debate

  Open Access

  • Pattern Recognition Receptors 100%
  • Immunotherapy 69%
  • Neoplasms 25%
  6 Scopus citations